Changes to the national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs between 2013 and 2016: a cross-sectional survey of 34 European countries

BACKGROUND: Hepatitis C virus (HCV) infection is the leading cause of cirrhosis, end-stage liver disease and hepatocellular carcinoma (HCC) worldwide. In Europe, people who inject drugs (PWID) represent the majority of HCV infections, but are often excluded from treatment. The aim of this study was...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Harm Reduct J
Huvudupphovsmän: Maticic, Mojca, Zorman, Jerneja Videcnik, Gregorcic, Sergeja, Schatz, Eberhard, Lazarus, Jeffrey V.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2019
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6509821/
https://ncbi.nlm.nih.gov/pubmed/31072401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-019-0303-9
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk